Related Experiment Video
Updated: Apr 28, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
1.4K
Bupropion in the depression-related sexual dysfunction: a systematic review
Valeska M Pereira, Oscar Arias-Carrión, Sergio Machado
1Laboratory of Panic and Respiration. Institute of Psychiatry - Federal University of Rio de Janeiro, Brazil. valeskapereira@gmail.com.
CNS & Neurological Disorders Drug Targets
|June 14, 2014
Summary
Bupropion offers an effective treatment for depression with fewer sexual side effects than SSRIs. It may even improve sexual function in some patients, presenting a viable alternative for managing depression.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Depression is a prevalent psychiatric disorder linked to various impairments.
- Sexual dysfunction affects a significant portion of the adult population.
- Antidepressants, particularly SSRIs, are associated with sexual dysfunction as a side effect.
Purpose of the Study:
- To review existing literature on bupropion's impact on sexual function in depressed individuals.
- To evaluate bupropion as a potential alternative antidepressant with a favorable sexual side effect profile.
Main Methods:
- Literature review of studies investigating bupropion and sexual function in depression.
- Analysis of reported effects of bupropion on sexual functioning compared to other antidepressants.
Main Results:
- Bupropion demonstrates comparable efficacy to other antidepressants.
- Bupropion is associated with a lower incidence of sexual dysfunction.
- Some studies indicate bupropion can enhance sexual function.
- Bupropion can be effective in treating antidepressant-emergent sexual dysfunction when combined with other agents.
Conclusions:
- Bupropion presents a potential alternative treatment for depression with reduced sexual side effects.
- Further research is needed to fully elucidate bupropion's role and benefits in managing depression and associated sexual dysfunction.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K
01:25Antidepressant Drugs: Overview
2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
379
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
379
01:21G-protein Coupled Receptors
90.7K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
90.7K
01:17Male Sexual Response: Erection & Ejaculation
31.0K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
31.0K